MDxHealth (NASDAQ:MDXH) reported quarterly losses of $(0.390) per share which missed the analyst consensus estimate of $(0.150) by 160 percent. The company reported quarterly sales of $19.398 million which beat the analyst consensus estimate of $18.136 million by 6.96 percent. This is a 50.48 percent increase over sales of $12.891 million the same period last year.
MDxHealth Q4 2023 GAAP EPS $(0.390) Misses $(0.150) Estimate, Sales $19.398M Beat $18.136M Estimate
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.